89bio, Inc.

ETNB

89bio, Inc.

ETNB

Insider Sentiment (TTM):

Last Purchase:2025-01-30Last Sale:2025-07-15Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2025-09-30Institutional Shares Owned:145,915,377Shares Outstanding:157,880,203Institutional Ownership Pct.:92.42%

Earnings Market Reaction:

Filing Date:N/APrice on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30
Assets
Cash And Cash Equivalents At Carrying Value	129	315	126	91	212	218	316	252	245	351	55	72
Marketable Securities Current	432	323	314	332	319	345	263	-	-	-	133	-
Assets Current
Assets Current	602	683	476	456	580	575	594	460	492	494	196	200
Restricted Cash Current	-	-	-	-	-	-	-	-	-	-	0	-
Prepaid Expense And Other Assets Current	40	44	36	32	48	12	15	11	14	13	8	7
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Right Of Use Asset	1	1	2	2	2	2	2	0	0	0	0	0
Other Assets Noncurrent	1	1	1	0	0	0	0	0	0	0	0	0
Assets	603	685	479	458	582	577	596	460	493	494	197	201
Liabilities And Stockhold…
Accounts Payable Current	15	15	15	19	17	15	9	11	11	17	13	14
Liabilities Current
Accrued Liabilities Current	24	22	20	19	19	20	21	14	15	7	12	13
Liabilities Current	40	38	36	39	42	38	30	25	26	24	25	34
Operating Lease Liability Current	1	1	1	1	1	1	0	0	0	0	0	0
Long Term Debt Current	-	-	-	-	5	2	-	-	-	-	-	7
Operating Lease Liability Noncurrent	1	1	1	1	1	2	2	0	0	0	0	0
Derivative Liabilities Noncurrent	0	0	1	0	-	-	0	-	-	-	-	-
Long Term Debt Noncurrent	36	36	36	36	20	23	25	25	24	24	20	13
Other Liabilities Noncurrent	5	5	4	4	4	4	4	-	-	-	-	-
Liabilities	82	80	78	80	67	67	60	50	51	48	45	48
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	1,529	1,501	1,225	1,083	1,073	1,020	993	828	825	790	467	444
Accumulated Other Comprehensive Income Loss Net Of…	0	0	1	1	-1	-1	0	-1	-1	-0	-0	-0
Stockholders Equity
Stockholders Equity	522	605	401	378	515	511	536	410	442	446	152	153
Retained Earnings Accumulated Deficit	-1,007	-896	-825	-706	-557	-509	-457	-417	-382	-344	-315	-291
Liabilities And Stockholders Equity	603	685	479	458	582	577	596	460	493	494	197	201
Preferred Stock Par Or Stated Value Per Share	-	-	0.001	-	-	-	0.001	-	-	-	0.001	-
Preferred Stock Shares Authorized	-	-	10	-	-	-	10	-	-	-	10	-
Preferred Stock Shares Issued	-	-	0	-	-	-	0	-	-	-	0	-
Preferred Stock Shares Outstanding	-	-	0	-	-	-	0	-	-	-	0	-
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	-	-	-	0.001	-
Common Stock Shares Authorized	200	200	200	200	200	200	200	-	-	-	100	-
Common Stock Shares Issued	148	146	120	106	105	95	93	-	-	-	51	-
Shares Outstanding	148	146	120	106	105	95	93	-	-	-	51	-

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

No price variance data available.

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30
Liquidity Ratios
Current Ratio	15.19	18.03	13.19	11.66	13.92	15.03	20.04	18.23	18.96	20.56	7.97	5.81
Quick Ratio	14.17	16.86	12.18	10.83	12.76	14.70	19.55	17.78	18.42	20.02	7.64	5.62
Working Capital	561.91M	645.06M	440.32M	417.08M	538.20M	536.54M	563.92M	434.31M	465.93M	469.62M	171.47M	165.43M
Leverage & Debt
Debt to Equity	0.16	0.13	0.19	0.21	0.13	0.13	0.11	0.12	0.11	0.11	0.30	0.31
Interest Coverage TTM	-78.17	-70.83	-72.71	-61.20	-53.70	-50.24	-31.54	-30.26	-30.39	-29.44	-53.20	-74.89
Debt Ratio	0.14	0.12	0.16	0.17	0.12	0.12	0.10	0.11	0.10	0.10	0.23	0.24
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-2.85	-2.64	-3.51	-2.70	-1.75	-1.72	-2.00	-1.66	-1.60	-1.98	-2.93	-2.19
Free Cash Flow Per Share TTM	-2.78	-2.73	-3.51	-2.62	-1.66	-1.45	-1.82	-1.60	-1.44	-1.63	-2.33	-1.74
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	157.83%	134.30%	158.16%	128.33%	47.18%	56.73%	39.37%	22.03%	12.73%	4.35%	13.21%	35.72%
EPS Growth (1Y)	63.03%	53.43%	75.47%	62.78%	9.29%	-13.05%	-31.84%	-24.46%	-69.05%	-60.08%	-34.63%	-42.29%
Calculated Values
Free Cash Flow TTM	-439.17M	-399.91M	-367.82M	-280.54M	-165.54M	-138.82M	-129.19M	-121.99M	-106.45M	-86.83M	-81.10M	-82.27M
Net Debt	-92.92M	-279.46M	-90.33M	-55.87M	-187.09M	-192.62M	-291.37M	-227.29M	-220.96M	-326.60M	-35.06M	-52.78M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-07-15Sale

Owner: Le-Nguyen, Quoc

Title: See Remarks

Shares: 10,461

Price/Share: $11.02

Value: $115,280.22

Shares Owned: 309,364

Relationship: Officer

Ownership: Direct

2025-04-15Sale

Owner: Le-Nguyen, Quoc

Title: See Remarks

Shares: 15,329

Price/Share: $5.95

Value: $91,207.55

Shares Owned: 328,323

Relationship: Officer

Ownership: Direct

2025-01-30Purchase

Owner: Kolchinsky, Peter, Shah R…

Title: -

Shares: 5,714,285

Price/Share: $8.75

Value: $49,999,993.75

Shares Owned: 19,554,319

Relationship: Director,TenPercentOwner

Ownership: Indirect

2025-01-22Purchase

Owner: Mcwherter, Charles

Title: -

Shares: 10,000

Price/Share: $6.71

Value: $67,100.00

Shares Owned: 25,000

Relationship: Director

Ownership: Direct

2025-01-15Sale

Owner: Le-Nguyen, Quoc

Title: See Remarks

Shares: 10,963

Price/Share: $6.49

Value: $71,149.87

Shares Owned: 271,833

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-07-15	Le-Nguyen, Quoc	Officer	See Remarks	Direct	Sale	10,461	11.02	$115,280.22	309,364	4
2025-04-15	Le-Nguyen, Quoc	Officer	See Remarks	Direct	Sale	15,329	5.95	$91,207.55	328,323	4
2025-01-30	Kolchinsky, Peter, Shah R…	Director,TenPercentOwner	-	Indirect	Purchase	5,714,285	8.75	$49,999,993.75	19,554,319	4
2025-01-22	Mcwherter, Charles	Director	-	Direct	Purchase	10,000	6.71	$67,100.00	25,000	4
2025-01-15	Le-Nguyen, Quoc	Officer	See Remarks	Direct	Sale	10,963	6.49	$71,149.87	271,833	4
2024-12-06	Palekar, Rohan	Director,Officer	Chief Executive Officer	Direct	Purchase	5,000	7.89	$39,450.00	471,236	4
2024-12-05	Mcwherter, Charles	Director	-	Direct	Purchase	10,000	8.00	$80,000.00	10,000	4
2024-11-22	Palekar, Rohan	Director,Officer	Chief Executive Officer	Direct	Purchase	10,000	8.35	$83,500.00	466,236	4
2024-10-30	Le-Nguyen, Quoc	Officer	See Remarks	Direct	Sale	27,955	8.12	$226,994.60	187,796	4
2024-04-01	Palekar, Rohan	Director,Officer	Chief Executive Officer	Direct	Sale	52,718	10.91	$575,153.38	459,171	4
2024-03-04	Kolchinsky, Peter, Ra Cap…	Director,TenPercentOwner	-	Indirect	Purchase	1,350,000	15.35	$20,722,500.00	12,431,584	4
2024-02-26	Palekar, Rohan	Director,Officer	Chief Executive Officer	Direct	Sale	4,477	10.76	$48,172.52	486,889	4
2023-12-29	Palekar, Rohan	Director,Officer	Chief Executive Officer	Direct	Sale	50,000	11.20	$560,000.00	301,225	4
2023-07-17	Laporte, Kathleen	Director	-	Direct	Sale	12,500	18.80	$235,000.00	0	4
2023-06-05	Palekar, Rohan	Director,Officer	Chief Executive Officer	Direct	Sale	15,000	20.00	$300,000.00	286,978	4
2023-06-01	Atkinson, Edward Morrow I…	Director	-	Direct	Sale	6,250	17.91	$111,937.50	0	4
2023-05-09	Le-Nguyen, Quoc	Officer	See Remarks	Direct	Sale	13,683	18.11	$247,799.13	164,971	4
2023-04-04	Martins, Ryan	Officer	Chief Financial Officer	Direct	Sale	8,721	14.95	$130,378.95	53,578	4
2023-03-28	Hayden, Michael R	Director	-	Indirect	Purchase	61,538	16.15	$993,838.70	61,538	4
2023-03-24	Ra, Capital Management, L…	Director,TenPercentOwner	-	Indirect	Purchase	2,461,538	16.25	$39,999,992.50	11,081,584	4
2023-03-23	Martins, Ryan	Officer	Chief Financial Officer	Direct	Sale	5,000	16.11	$80,550.00	53,578	4
2023-03-23	Palekar, Rohan	Director,Officer	Chief Executive Officer	Direct	Sale	15,000	16.00	$240,000.00	269,080	4
2023-03-01	Atkinson, Edward Morrow I…	Director	-	Direct	Sale	10,000	13.60	$136,000.00	0	4
2023-02-21	Martins, Ryan	Officer	Chief Financial Officer	Direct	Sale	2,540	13.89	$35,280.60	58,578	4
2023-02-08	Martins, Ryan	Officer	Chief Financial Officer	Direct	Sale	1,480	14.41	$21,326.80	32,868	4
2023-02-03	Martins, Ryan	Officer	Chief Financial Officer	Direct	Sale	3,592	12.90	$46,336.80	35,368	4
2023-01-03	Martins, Ryan	Officer	Chief Financial Officer	Direct	Sale	5,947	12.51	$74,396.97	36,368	4
2022-10-18	Ra, Capital Nexus Fund, L…	Director,TenPercentOwner	-	Indirect	Purchase	1,172,741	7.65	$8,971,468.65	8,955,410	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2025-09-30

92.42%

Inst. Shares: 145,915,377

Shares Outstanding: 157,880,203

2025-06-30

101.34%

Inst. Shares: 159,990,394

Shares Outstanding: 157,880,203

2025-03-31

103.43%

Inst. Shares: 151,380,869

Shares Outstanding: 146,365,115

2024-12-31

114.53%

Inst. Shares: 119,927,938

Shares Outstanding: 104,714,613

2024-09-30

96.03%

Inst. Shares: 102,823,795

Shares Outstanding: 107,075,197

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2025-09-30	145,915,377	157,880,203	92.42%
2025-06-30	159,990,394	157,880,203	101.34%
2025-03-31	151,380,869	146,365,115	103.43%
2024-12-31	119,927,938	104,714,613	114.53%
2024-09-30	102,823,795	107,075,197	96.03%
2024-06-30	101,680,009	99,831,111	101.85%
2024-03-31	96,991,413	95,846,740	101.19%
2023-12-31	92,407,659	71,172,870	129.84%
2023-09-30	69,863,350	76,336,050	91.52%
2023-06-30	73,995,726	74,126,569	99.82%
2023-03-31	61,729,924	53,171,370	116.10%
2022-12-31	39,544,860	34,806,349	113.61%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

89bio, Inc. (ETNB) — SEC Financial Statements & Analysis

89bio, Inc. (ETNB) is a pharmaceutical preparations company, incorporated in DE. 89bio, Inc. trades on None as: ETNB. Based on its latest SEC filing (Form 10-Q, period ending 2025-06-30), 89bio, Inc. reported a Debt-to-Equity ratio of 0.16x. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.16x

Data as of 2025-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is 89bio, Inc. in?

89bio, Inc. (ETNB) operates in the Pharmaceutical Preparations industry.

What exchange does ETNB trade on?

89bio, Inc. (ETNB) trades on the None.

Where is 89bio, Inc. incorporated?

89bio, Inc. is incorporated in DE.

89bio, Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

89bio, Inc. (ETNB) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.
Main Street's price.

89bio, Inc. (ETNB) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.